Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Stockholders' Equity (Parenthetical)

v3.20.4
Consolidated Statement of Stockholders' Equity (Parenthetical) - USD ($)
$ in Thousands
 12 Months Ended
Sep. 27, 2020
Sep. 29, 2019
Gross proceeds for exercise of warrants $ 72
Fair market value of warranty liability   $ (75)
Restricted common shares issued, value [1]  
Common shares repurchased [2] $ 200  
Independent Board of Directors [Member]    
Restricted common shares issued, shares 100,000  
Share-based compensation vesting percentage 20.00%  
Share-based compensation vesting period 5 years  
Restricted common shares issued, value $ 525  
Amortized over the vesting period, shares 300,000  
Warrant [Member]    
Exercise of warrants for common shares   $ 1.50
Gross proceeds for exercise of warrants   $ 72
Fair market value of warranty liability   $ (48)
[1] 100,000 restricted common shares issued to each of the Independent Board of Directors (Rimmy Malhotra, Dale Lehman, Larry Hagenbuch) on April 30, 2020 with 20% vesting as of each January 1 each year over a five-year period. The value of the shares at issue date is $525,000 for 300,000 shares to be amortized over the vesting period.
[2] Common shares repurchased in the open market between June 11, 2020 and September 27, 2020 for $200 thousand and held in treasury stock using the cost method.